Our weekly list of news, reports, and information about home health and hospice care. Learn about new studies, trends, CMS regulations and more.
Amedisys, Inc. (NASDAQ:AMED) stock enjoyed an overall uptrend of 138.87% from the beginning of 2018. The closing share price quoted for November 16, 2018 was $125.91. The 3.21% rally might have been tempting for an investor to buy at this point and in fact that would prove a good idea, as sell-side analysts think there is almost 11.19% more gain yet to come for shareholders. Analysts seemed to set $140 as highest price target on its way to greater gains. The average 12-month price target they expect from the stock is $125.91. This mean price target represents 0% downside over its previous closing price. The median price target they presented was $125 for the next 12-months, which suggests a -0.72% upside from current levels. Some analysts have a lowest price target on the stock of $104, which would mean a -17.4% gain in value.
Home Healthcare Software Market – What Factors Will Drive the Market in Upcoming Years and How it is Going to Impact on Global Industry
Home healthcare software is the application of information processing, involving both computer hardware and software that deals with the storage, retrieval, sharing and use of health care information, data and knowledge for communication, and decision-making. The global market report is a systematic research of the global Home Healthcare Software Market portraying the current state of affairs in the market. Further, it offers an estimation of the market measure as far as esteem and in volume and discusses the key fragments and the topographical subdivisions of the market for Home Healthcare Software advertise in subtle elements.
The Home Health Care Market Report used to change the dynamics of the Market Research industry by providing quality intelligence backed by data.This report is a valuable source of guidance for companies and individuals offering Industry Chain Structure, Business Strategies and Proposals for New Project Investments.It provides a futuristic perspective on the various factors driving or detaining the growth of the market. t helps in formulating knowledgeable business decisions by having wide-ranging insights of market and by making a detailed analysis of market segments.Your requirement for Home Health Care market forecasting is fulfilled by our exclusive quantitative intelligence.
The CMS wants to make sure it's using the right quality measures to track care given by home health agencies, which costs the agency around $18 billion every year. The agency has issued numerous new quality measures for HHS going back to 1999, but it's unclear what, if any, impact on care they've had, according to a federal notice. "Despite the established use of CMS quality measures in HHAs, CMS lacks information regarding the impact of their use and how HHAs are responding to them," the agency said. The survey, if approved by the White House, would begin in August 2019. Results of the survey would be published by 2021 in peer-reviewed journals.